Eva Lengyelova has worked in the clinical development field since 2013. Eva began their career at Parexel in 2013 as a Clinical Trial Assistant. In 2015, they moved to Bendalls Group, where they worked as an Executive Assistant to the CEO & Office Manager. In 2017, Eva joined Clarity Pharmaceuticals, where they have held a variety of roles, including Director of Clinical Development, Clinical Development Manager, Clinical Project Manager, Associate Project Manager, and Clinical Research Analyst.
Eva Lengyelova has a diverse educational background. Eva began their studies in 2008 at Comenius University in Bratislava, Faculty of Natural Sciences, Slovakia, where they earned a Bachelor's Degree in Molecular Biology in 2011. Eva then completed a Master's Degree in Biomedicine at the same institution in 2013. Eva then went on to pursue a Masters of Clinical Trials Research at The University of Sydney, Faculty of Medicine, which they completed in 2019. Additionally, Eva has an Advanced Diploma of Management from Strathfield College Sydney Australia.
July, 2022 - present
May, 2021
July, 2019
November, 2018
April, 2017
Director of Clinical Development at MediBeacon
Director of Clinical Development at Maryland Addiction Recovery Center
Director of Clinical Development at Elypta
Director of Clinical Development at Etiometry
Director of Clinical Development at Vision Innovation Partners